Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urocell
- Development stage
- Unknown
- Lead developer
- Innovacell Biotechnology
- Modality
- Cell Therapies
- Administration
- Intramuscular, Intralesional
01
Overview
Urocell (ICES13) is an autologous cell-based advanced therapy medicinal product (ATMP) developed by Innovacell for the treatment of stress urinary incontinence (SUI) and urinary sphincter insufficiency. The therapy consists of the patient's own (autologous) myoblasts and fibroblasts combined with collagen as a carrier material. It is administered via transurethral ultrasound-guided injection: fibroblasts mixed with collagen are injected into the urethral submucosa to address mucosal atrophy, while myoblasts are injected directly into the rhabdosphincter to reconstruct muscle and repair morphological and functional defects. By leveraging the body's own regenerative capacity, Urocell aims to restore sphincter muscle function. It has completed Phase IIb clinical trials in Europe and is in preparation for Phase III development.
- Brand names
- Urocell
- Other names
- autologous myoblasts and fibroblastsautologous skeletal muscle-derived cells
Beyond the preview
Go deeper on Urocell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Urocell.